SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-200541
Filing Date
2023-08-01
Accepted
2023-08-01 16:08:03
Documents
18
Period of Report
2023-07-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d534556d8k.htm   iXBRL 8-K 41641
2 EX-4.1 d534556dex41.htm EX-4.1 88536
3 EX-10.1 d534556dex101.htm EX-10.1 245604
4 EX-10.2 d534556dex102.htm EX-10.2 143309
5 EX-99.1 d534556dex991.htm EX-99.1 10719
10 GRAPHIC g534556g0801111923098.jpg GRAPHIC 2640
  Complete submission text file 0001193125-23-200541.txt   818880

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA cmra-20230731.xsd EX-101.SCH 3898
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cmra-20230731_def.xml EX-101.DEF 14072
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE cmra-20230731_lab.xml EX-101.LAB 23307
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cmra-20230731_pre.xml EX-101.PRE 15105
12 EXTRACTED XBRL INSTANCE DOCUMENT d534556d8k_htm.xml XML 5281
Mailing Address 12 GILL STREET SUITE 4650 WOBURN MA 01801
Business Address 12 GILL STREET SUITE 4650 WOBURN MA 01801 (617)871-2101
Comera Life Sciences Holdings, Inc. (Filer) CIK: 0001907685 (see all company filings)

IRS No.: 874706968 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41403 | Film No.: 231131730
SIC: 2834 Pharmaceutical Preparations